_1777294237270_124456903.png&w=64&q=75){kind=small}
Weight-loss drugs miss Nobel prize
The 2026 Nobel Prizes did not award the Nobel Prize in Medicine for research related to weight-loss drugs and appetite-regulating hormones, despite many expectations of a win for research involving GLP-1, which led to the development of medications such as "Ozempic" for the treatment of diabetes and obesity. Instead, scientists Carl Desruth, Peter Hegmann, and Georg Nagel received the Nobel Prize in Medicine for their discoveries concerning light-controlled ion channels. This discovery has contributed to understanding the brain and nervous system, and has played a role in developing optogenetic techniques that use light to control brain cells. These techniques are currently used to study neurological and psychiatric disorders, as well as to restore vision.
Notice: This Is an AI-Generated Summary
Comments (0)